[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.168.87. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
June 16, 2004

C-Reactive Protein and Risk of Colon Cancer

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;291(23):2818-2819. doi:10.1001/jama.291.23.2818-b

To the Editor: Dr Erlinger and colleagues1 reported that C-reactive protein (CRP) levels were associated with risk of colon cancer. We have suggested that CRP is not merely a nonspecific marker of inflammation but has several important proinflammatory effects.2,3 In particular, CRP may activate endothelial cells, monocytes and smooth muscle cells, induce expression of adhesion molecules,2 chemoactractants,3 tissue factor, and activate the NF-κB pathway.4 Although we are not aware of any studies on the effect of CRP on cancer cells or on epithelial cells of the gastrointestinal tract, expression of adhesion molecules is important for cancer invasion and activation of the NF-κB pathway may have important oncogenic effects.5

First Page Preview View Large
First page PDF preview
First page PDF preview
×